Stopping Overdoses of Fentanyl Analogues Act

Stopping Overdoses of Fentanyl Analogues Act

This bill permanently adds fentanyl-related substances to schedule I of the Controlled Substances Act. (A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.)

Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires December 31, 2024.

Bill 118 hr 1291, also known as the Stopping Overdoses of Fentanyl Analogues Act, is a piece of legislation introduced in the US Congress. The main purpose of this bill is to combat the growing opioid crisis by expanding the list of controlled substances to include fentanyl analogues.

Fentanyl analogues are synthetic opioids that are similar in structure to fentanyl, a powerful and highly addictive drug that is responsible for a large number of overdose deaths in the United States. By adding fentanyl analogues to the list of controlled substances, law enforcement agencies will have more tools to crack down on the production and distribution of these dangerous drugs.

The bill also includes provisions to increase penalties for individuals caught trafficking fentanyl analogues and to provide resources for law enforcement agencies to better detect and respond to cases involving these substances. Additionally, the bill aims to improve coordination between federal, state, and local agencies in the fight against opioid abuse. Overall, the Stopping Overdoses of Fentanyl Analogues Act is a comprehensive piece of legislation that seeks to address the opioid crisis by targeting the production and distribution of fentanyl analogues. If passed, this bill could play a significant role in reducing the number of overdose deaths caused by these dangerous substances.